DEBRA International research grants

Dystrophic Epidermolysis Bullosa Research Association (DEBRA) is seeking grant applications in the following priority areas: 

• advance the understanding of EB’s pathomechanism(s), thus paving the way for new therapeutic concepts 

• contribute to disease-modifying or curative therapies, including those addressing systemic aspects of the disease

• prevent or treat severe consequences of EB

• improve clinical care and relevant symptom relief for people affected by EB

• address current infrastructure and technological challenges, as well as data gaps to accelerate new, effective treatments and facilitate therapy access for patients.

Funding: €90,000 per year 
Duration: 3 years 

Research Authority due date: 10.8.25

EOI (required) due date: 17.8.25

Full proposal due date: 17.11.25